Operating Team

+ MICHAEL HARRISON, CHIEF EXECUTIVE OFFICER & CHAIRMAN OF THE BOARD

  • 35 years experience in investment banking with interests in the resource, energy and biotech sectors
  • Responsible for raising in excess of US$1 billion in funding for private and publicy traded companies
  • Served on the Board of Directors for numerous international publicly listed companies

+ DR. FADIA SAAD, PRESIDENT

  • 20 years experience in the biotechnology and pharma space, with expertise in bridging science and business
  • Previous executive positions in a number of biotechnology companies including Aspreva Pharmaceuticals, MedBiogene and Green Sky Labs

+ JON BLOODWORTH, CHIEF OPERATING OFFICER

  • Three decades of senior executive management and legal experience in disruptive technologies, with an emphasis on intellectual property protection and licensing, commercial negotiations, finance and venture development
  • Holds a law degree and is an active member of the State Bar of California

+ DR. RICHARD SAYRE, CHIEF SCIENTIFIC OFFICER

  • One of the top Research Scientists at Los Alamos National Laboratory and the New Mexico Consortium
  • Extensive biotech experience in universities, national laboratories, and the private sector
  • One of the top 5 crop scientists who could change the world, according to Nature journal
  • Author of over 130 biotechnology papers and patents, with over 7000 citations
  • Received over US$100 million in grant funding for various projects

+ KIMBERLY HARRISON, CHIEF DEVELOPMENT OFFICER

  • 25 years experience as an entrepreneur across industries
  • Experienced in strategy, product development, VC funding, patents, distribution/licensing, and government relations
  • Served on numerous international product certifications and standardization committees

+ DR. KONSTANTINOS LYMPEROPOULOS, SCIENTIST

  • PhD in Biochemistry from the University of Oxford with a solid scientific background in biochemistry, virology and biophysics
  • Expertise in bio-molecular interactions, novel technology platforms and gene therapy
  • Author of 11 publications

+ DR. GUOHUA (KAREN) YIN, SCIENTIST

  • PhD in Molecular Plant Pathology from the State Key Laboratory of Crop Biology in Shandong China
  • Skilled in molecular biology and biotechnology such as next-generation sequencing and re-sequencing
  • Author of 45 publications with another 11 under review or in preparation

+ DR. TATIANA VINOGRADOVA-SHAH, SCIENTIST

  • PhD in Cell Biology from the Institute of Experimental Cardiology, Cardiology Research Center, Moscow, Russia
  • Expertise in cell and developmental biology
  • Author of 11 publications

+ DR. PEDRO MIGUEL MELO DA COSTA NUNES, SCIENTIST

  • PhD in Biology from the Instituto Superior de Agronomia, Technical University of Lisbon, Lisbon, Portugal
  • Expertise in plant Argonaute diversity and function
  • Author of 22 publications

+ SHANNON FLYNN, TECHNICIAN

  • 20 years experience in the Department of Energy's environmental science and restoration departments